ARF6 and intellectual disability, X-linked 1: Identification of a downregulation of Arf6-GTP as the key step by which fever provides benefit may be further verified in our murine models using drugs [31,32,33,34] which can decrease levels of Arf6-GTP, thereby providing a precision medicine approach to treat IQSEC2 disease.